Clearly, more research is needed to elucidate the nAChR subtypes expressed in the gut-brain axis, their interactions with bacteria, and the effects of experimental nicotinic IBD therapeutics on commensal bacteria. The gene discussed is CHRNA4; the disease is inflammatory bowel disease.